Free Trial

Lancashire (LRE) Competitors

Lancashire logo
GBX 593 +6.00 (+1.02%)
As of 07/11/2025 11:49 AM Eastern

LRE vs. MDC, ROAD, CCT, PRIM, CCS, EME, PHM, GEO, J, and MTH

Should you be buying Lancashire stock or one of its competitors? The main competitors of Lancashire include Mediclinic International (MDC), Roadside Real Estate (ROAD), The Character Group (CCT), Primorus Investments (PRIM), Crossword Cybersecurity (CCS), Empyrean Energy (EME), Phimedix Plc (PHM.L) (PHM), Georgian Mining (GEO), Jacobs Engineering Group (J), and Mithras Investment Trust (MTH). These companies are all part of the "construction" industry.

Lancashire vs. Its Competitors

Mediclinic International (LON:MDC) and Lancashire (LON:LRE) are both construction companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

Lancashire has a consensus target price of GBX 663, suggesting a potential upside of 11.80%. Given Lancashire's stronger consensus rating and higher possible upside, analysts clearly believe Lancashire is more favorable than Mediclinic International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mediclinic International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Lancashire
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

39.2% of Mediclinic International shares are owned by institutional investors. Comparatively, 60.5% of Lancashire shares are owned by institutional investors. 48.9% of Mediclinic International shares are owned by company insiders. Comparatively, 0.6% of Lancashire shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Lancashire has a net margin of 37.12% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 10.76% beat Mediclinic International's return on equity.

Company Net Margins Return on Equity Return on Assets
Mediclinic International4.99% 5.50% 2.30%
Lancashire 37.12%10.76%6.75%

In the previous week, Lancashire had 4 more articles in the media than Mediclinic International. MarketBeat recorded 4 mentions for Lancashire and 0 mentions for Mediclinic International. Mediclinic International's average media sentiment score of 1.17 beat Lancashire's score of -0.08 indicating that Mediclinic International is being referred to more favorably in the media.

Company Overall Sentiment
Mediclinic International Positive
Lancashire Neutral

Mediclinic International has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Lancashire has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500.

Mediclinic International pays an annual dividend of GBX 3 per share. Lancashire pays an annual dividend of GBX 18 per share and has a dividend yield of 3.0%. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Lancashire pays out 34.3% of its earnings in the form of a dividend. Lancashire is clearly the better dividend stock, given its higher yield and lower payout ratio.

Lancashire has lower revenue, but higher earnings than Mediclinic International. Mediclinic International is trading at a lower price-to-earnings ratio than Lancashire, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mediclinic International£3.38B0.00£169M£0.23N/A
Lancashire£536.12M3.34£199.02M£52.4911.30

Summary

Lancashire beats Mediclinic International on 13 of the 17 factors compared between the two stocks.

Get Lancashire News Delivered to You Automatically

Sign up to receive the latest news and ratings for LRE and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LRE vs. The Competition

MetricLancashireInsurance IndustryFinancial SectorLON Exchange
Market Cap£1.79B£3.01B£6.16B£3.00B
Dividend Yield0.19%1.22%4.21%5.02%
P/E Ratio11.305.7613.27150.83
Price / Sales3.34122.011,738.23314,599.95
Price / Cash2.172.04128.1027.97
Price / Book0.971.561.914.58
Net Income£199.02M£474.99M£1.23B£5.90B
7 Day Performance1.37%-0.78%11.18%11.51%
1 Month Performance4.59%6.92%7.30%8.27%
1 Year Performance-2.79%16.36%17.74%32.75%

Lancashire Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LRE
Lancashire
3.2934 of 5 stars
GBX 593
+1.0%
GBX 663
+11.8%
-2.8%£1.79B£536.12M11.30393News Coverage
Analyst Forecast
MDC
Mediclinic International
N/AN/AN/AN/A£3.69B£3.38B2,178.261,640News Coverage
ROAD
Roadside Real Estate
N/AGBX 50.10
-2.2%
N/A+339.2%£69.37M£416.20K1.603,790
CCT
The Character Group
N/AGBX 274
+1.5%
N/A-11.4%£50.64M£116.84M9.701,540Dividend Increase
PRIM
Primorus Investments
N/AGBX 3.25
+3.2%
N/A+13.4%£4.55MN/A4.9012,800Gap Up
High Trading Volume
CCS
Crossword Cybersecurity
N/AN/AN/AN/A£1.95M£4.19M-43.751,540News Coverage
Gap Down
High Trading Volume
EME
Empyrean Energy
N/AGBX 0.02
-5.0%
N/A-93.4%£769KN/A-0.0135,500Gap Down
PHM
Phimedix Plc (PHM.L)
N/AN/AN/AN/A£327KN/A-1.586,520Gap Down
High Trading Volume
GEO
Georgian Mining
N/AGBX 0.16
+11.4%
N/A-86.7%£209K£233.00K-0.0215,800News Coverage
Gap Down
J
Jacobs Engineering Group
N/AN/AGBX 200
+∞
N/A£0.00N/A0.0060,000High Trading Volume
MTH
Mithras Investment Trust
N/AN/AN/AN/A£0.00N/A0.001,920Gap Up

Related Companies and Tools


This page (LON:LRE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners